8.8
CVSSv3

CVE-2007-6763

Published: 31/07/2019 Updated: 12/08/2019
CVSS v2 Base Score: 6.5 | Impact Score: 6.4 | Exploitability Score: 8
CVSS v3 Base Score: 8.8 | Impact Score: 5.9 | Exploitability Score: 2.8
VMScore: 578
Vector: AV:N/AC:L/Au:S/C:P/I:P/A:P

Vulnerability Summary

SAS Drug Development (SDD) prior to 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Vulnerability Trend

Vulnerable Product Search on Vulmon Subscribe to Product

sas sas drug development